Industry News
Pharmaceutical Industry News
How The Opioid Crisis Turned Pharmacists Into Cops
How the opioid crisis changed pharmacists’ relationships with their patients.
Jill Stein’s Third-Party Candidacy
Readers discuss Democrats’ concerns that her bid will throw the election to Donald Trump. Also: Harris ads; drug-free treatments; regretting email.
U.S. Study on Puberty Blockers Goes Unpublished Because of Politics, Doctor Says
The leader of the long-running study said that the drugs did not improve mental health in children with gender distress and that the finding might be weaponized by opponents of the care.
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
Biden Mocks Trump’s ‘Concept of a Plan’ to Replace Obamacare
During a visit to New Hampshire to discuss the cost of prescription drugs, President Biden warned that a second Trump presidency could lead millions of people to lose health care.
Biden to Propose That Insurers Cover Over-the-Counter Birth Control
The new rules under the Affordable Care Act would include emergency contraception, a newly approved nonprescription birth control pill, spermicides and condoms.
States Revive Lawsuit to Sharply Curb Access to Abortion Pill
The Supreme Court ruled in June that the original plaintiffs, anti-abortion doctors and groups, did not have standing to sue. Now three states are trying to continue the legal fight.
In L.A., Street Psychiatrists Offer the Homeless a Radical Step Forward
The crisis of homelessness is pushing American psychiatry to places it has not gone before — like sidewalk injections of antipsychotics.
Sammy Basso, Advocate for Progeria Research, Is Dead at 28
One of about 150 people known to have a rare condition that causes rapid aging, he sought to raise awareness and participated in the search for a cure.
CVS Ousts Karen Lynch as C.E.O. and Shares Fall
Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state of the company’s finances.
Why We May Soon Use Ozempic to Treat Addiction
Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating addiction.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
U.S. Races to Replace IV Fluid Supplies After Hurricane Helene
The F.D.A. has authorized shipments from overseas plants to ease shortages of IV bags caused by Hurricane Helene as hospitals begin rationing fluids to protect the sickest patients.
Mi pesadilla con el virus del Nilo Occidental
A medida que el cambio climático facilita la proliferación de mosquitos en muchos lugares, la enfermedad del virus del Nilo Occidental se perfila como una de las mayores amenazas de salud.
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
Anthony Fauci: My West Nile Virus Nightmare
What it’s like to get the neglected disease.
Growing Cannabis and Opium Poppies May Be Key to U.S. Supply Chains
After supply chain disruptions that made critical medicines scarce, a federal effort is underway to ensure domestic stocks of pharmaceutical ingredients.
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded versions of the medications.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.